Cancer BiologyBritish Journal of HaematologyPeer-reviewed
Comprehensive Analysis of 177Lu-lilotomab Satetraxetan in Lymphoma Cell Lines: Implications for Precision Radioimmunotherapy and Combination Schemes
Sebastian Patzke, Filippo Spriano, Katrine B. Melhus…·Francesco Bertoni
This paper evaluates the effectiveness of 177Lu-lilotomab satetraxetan in lymphoma cell lines, showing it is more effective in CD37-positive B-cell lymphomas and identifies potential biomarkers and synergistic combinations.
2 citations